Approvals in 2018 brought the total number of U.S. Food and Drug Administration-licensed biosimilars well into the double digits — and more are in the pipeline.
The success of IG manufacturing assures that today and in the future, patients in need have access to this unique therapeutic.
Thousands of studies are investigating how and why cancer metastasizes and how to more effectively treat it.
Research is paving the way for new preventive vaccines for many different illnesses.
Parents who choose not to vaccinate their children reduce the community immunity threshold that can result in a return of preventable diseases.
The right-to-die movement advocating the passage of state legislation to allow medical aid in dying is gaining momentum.
Debunking some of the misconceptions about the world’s leading cause of blindness could help many people get the treatment they need.
Potentially curative gene therapy is in the works for hemophilia.
Pricing of drugs is far more complex than the big, bad pharma price-gouging narrative.
For the many different types of diabetes, there are no cures yet, but a host of successful treatments available, with myriad more being studied.
Private and public healthcare challenges grow as an aging population grapples with the ramifications of increasing numbers of HIV-positive senior citizens.
Hereditary angioedema is a rare genetic disease for which replacement therapy provides safe and highly effective treatment.